Health
New antitumor vaccines control melanoma growth in preclinical models – News-Medical.Net
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical m…
Reviewed by Emily Henderson, B.Sc.Sep 11 2020
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.
Study results were published online in Cancer Immunology Research, a journal of the American Association for Cancer Research, and support exploration of this immunotherapy approach for a…
-
Noosa News23 hours agoCareer Moves: WGC Lawyers – Proctor
-
Noosa News23 hours agoMan dies after dispute with security outside bar
-
Noosa News24 hours agoMan dies while restrained by security staff in Brisbane’s Fortitude Valley
-
Noosa News24 hours agoTom Lynagh boosts Wallabies’ selection hopes for British and Irish Lions series